100 related articles for article (PubMed ID: 29100314)
1. Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis.
Misawa K; Imai A; Mochizuki D; Misawa Y; Endo S; Hosokawa S; Ishikawa R; Mima M; Shinmura K; Kanazawa T; Mineta H
Oncotarget; 2017 Sep; 8(44):76318-76328. PubMed ID: 29100314
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer.
Misawa K; Mima M; Satoshi Y; Misawa Y; Imai A; Mochizuki D; Nakagawa T; Kurokawa T; Oguro M; Ishikawa R; Yamaguchi Y; Endo S; Kawasaki H; Kanazawa T; Mineta H
Sci Rep; 2020 Jan; 10(1):1007. PubMed ID: 31974445
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
5. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
6. Association of TET3 epigenetic inactivation with head and neck cancer.
Misawa K; Imai A; Mochizuki D; Mima M; Endo S; Misawa Y; Kanazawa T; Mineta H
Oncotarget; 2018 May; 9(36):24480-24493. PubMed ID: 29849955
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis.
Misawa K; Mochizuki D; Imai A; Mima M; Misawa Y; Mineta H
Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29361757
[TBL] [Abstract][Full Text] [Related]
8. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
9. Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer.
Misawa K; Kanazawa T; Mochizuki D; Imai A; Mima M; Yamada S; Morita K; Misawa Y; Shinmura K; Mineta H
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30901947
[TBL] [Abstract][Full Text] [Related]
10. RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis.
Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; Laan BF; van Criekinge W; de Meyer T; Denil S; van der Vegt B; Wisman GB; Roodenburg JL; Schuuring E
Epigenetics; 2016 Sep; 11(9):653-663. PubMed ID: 27379752
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H
Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Sailer V; Gevensleben H; Dietrich J; Goltz D; Kristiansen G; Bootz F; Dietrich D
PLoS One; 2017; 12(6):e0179412. PubMed ID: 28617833
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
16. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
Huber GF; Albinger-Hegyi A; Soltermann A; Roessle M; Graf N; Haerle SK; Holzmann D; Moch H; Hegyi I
Cancer; 2011 Oct; 117(20):4659-70. PubMed ID: 21448927
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas.
Michikawa C; Uzawa N; Kayamori K; Sonoda I; Ohyama Y; Okada N; Yamaguchi A; Amagasa T
Oral Oncol; 2012 Apr; 48(4):320-4. PubMed ID: 22178206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]